471 related articles for article (PubMed ID: 17097724)
41. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
[TBL] [Abstract][Full Text] [Related]
42. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
Leriche L; Schwartz JC; Sokoloff P
Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123
[TBL] [Abstract][Full Text] [Related]
43. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
Nakaya K; Nakagawasai O; Arai Y; Onogi H; Sato A; Niijima F; Tan-No K; Tadano T
Behav Brain Res; 2011 Mar; 218(1):165-73. PubMed ID: 21130810
[TBL] [Abstract][Full Text] [Related]
45. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
46. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?
Olivier B; Leahy C; Mullen T; Paylor R; Groppi VE; Sarnyai Z; Brunner D
Psychopharmacology (Berl); 2001 Jul; 156(2-3):284-90. PubMed ID: 11549230
[TBL] [Abstract][Full Text] [Related]
47. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating.
Feifel D; Priebe K
Psychopharmacology (Berl); 1999 Sep; 146(2):175-9. PubMed ID: 10525752
[TBL] [Abstract][Full Text] [Related]
48. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
Fijał K; Popik P; Nikiforuk A
Psychopharmacology (Berl); 2014 Jan; 231(1):269-81. PubMed ID: 23954911
[TBL] [Abstract][Full Text] [Related]
49. Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain.
Depoortere R; Perrault G; Sanger DJ
Behav Pharmacol; 1997 Aug; 8(4):364-72. PubMed ID: 9832995
[TBL] [Abstract][Full Text] [Related]
50. Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.
Duncan GE; Inada K; Koller BH; Moy SS
Brain Res; 2010 Jan; 1307():166-76. PubMed ID: 19840778
[TBL] [Abstract][Full Text] [Related]
51. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function.
Benneyworth MA; Basu AC; Coyle JT
Psychopharmacology (Berl); 2011 Jan; 213(1):143-53. PubMed ID: 20865248
[TBL] [Abstract][Full Text] [Related]
52. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
Morimoto T; Hashimoto K; Yasumatsu H; Tanaka H; Fujimura M; Kuriyama M; Kimura K; Takehara S; Yamagami K
Neuropsychopharmacology; 2002 Apr; 26(4):456-67. PubMed ID: 11927170
[TBL] [Abstract][Full Text] [Related]
53. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
54. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M
Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196
[TBL] [Abstract][Full Text] [Related]
55. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan.
Browman KE; Komater VA; Curzon P; Rueter LE; Hancock AA; Decker MW; Fox GB
Behav Brain Res; 2004 Aug; 153(1):69-76. PubMed ID: 15219708
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
Porter JH; Walentiny DM; Philibin SD; Vunck SA; Crabbe JC
Behav Pharmacol; 2008 Sep; 19(5-6):530-42. PubMed ID: 18690107
[TBL] [Abstract][Full Text] [Related]
58. Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.
Anastasio NC; Johnson KM
Pharmacol Biochem Behav; 2008 Oct; 90(4):569-77. PubMed ID: 18544461
[TBL] [Abstract][Full Text] [Related]
59. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice.
Barr AM; Fish KN; Markou A
Neuropharmacology; 2007 Mar; 52(4):1114-23. PubMed ID: 17261317
[TBL] [Abstract][Full Text] [Related]
60. Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats.
Andersen MP; Pouzet B
Psychopharmacology (Berl); 2001 Jul; 156(2-3):291-304. PubMed ID: 11549231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
